3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
4
Stomach Neoplasms
3
Gastrointestinal Neoplasms
3
Rectal Neuroendocrine Tumors
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Small Size Gastrointestinal Stromal Tumors
1
Precancerous Conditions
1
Hemorrhage
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Polyps
1
Clinical Stage III Gastric Cancer AJCC v8
1
Benign Colon Tumors
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
19
pembrolizumab
13
Fluorouracil
12
Leucovorin
11
Capecitabine
11
Paclitaxel
10
Gemcitabine
8
Docetaxel
8
zolbetuximab
6
cemiplimab
6
Cisplatin
6
Albumin-Bound Paclitaxel
6
durvalumab
5
Ramucirumab
5
Radiotherapy
5
Irinotecan
4
Cyclophosphamide
4
130-nm albumin-bound paclitaxel
4
trastuzumab deruxtecan
3
tislelizumab
3
lenvatinib
3
enzalutamide
3
darolutamide
3
Trastuzumab
3
Taxes
3
S 1 (combination)
3
Radiosurgery
3
Pemetrexed
3
Nivolumab
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Endoscopic Mucosal Resection
×
1 year
×
Clear all
No trials found.